| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
10,928 |
9,887 |
$1.49M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
5,288 |
3,972 |
$1.44M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
9,684 |
8,948 |
$1.26M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
7,495 |
6,256 |
$843K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
15,174 |
11,983 |
$829K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
3,770 |
3,354 |
$532K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
6,252 |
1,727 |
$337K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,110 |
916 |
$326K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,256 |
1,111 |
$318K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
1,212 |
739 |
$318K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
824 |
729 |
$270K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
3,114 |
2,327 |
$221K |
| 80053 |
Comprehensive metabolic panel |
22,412 |
18,776 |
$195K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,934 |
1,116 |
$159K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
1,902 |
704 |
$131K |
| 80061 |
Lipid panel |
4,836 |
4,442 |
$120K |
| 84443 |
Thyroid stimulating hormone (TSH) |
4,601 |
4,163 |
$118K |
| G0378 |
Hospital observation service, per hour |
1,842 |
859 |
$105K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,411 |
3,478 |
$99K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
1,108 |
403 |
$98K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
24,899 |
19,948 |
$93K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,972 |
1,676 |
$89K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
377 |
343 |
$88K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
1,266 |
551 |
$81K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
386 |
336 |
$74K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
578 |
542 |
$72K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
2,723 |
2,511 |
$72K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
4,171 |
3,880 |
$66K |
| 71046 |
Radiologic examination, chest; 2 views |
1,297 |
1,144 |
$49K |
| 87631 |
|
841 |
779 |
$48K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
1,549 |
651 |
$47K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
2,958 |
2,491 |
$47K |
| 20610 |
|
649 |
401 |
$46K |
| 11721 |
|
3,111 |
2,144 |
$46K |
| 36415 |
Collection of venous blood by venipuncture |
22,904 |
17,371 |
$45K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
137 |
101 |
$34K |
| 97750 |
|
405 |
367 |
$32K |
| 11056 |
|
807 |
401 |
$30K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
3,227 |
2,849 |
$30K |
| 97162 |
|
368 |
331 |
$26K |
| 97161 |
|
243 |
222 |
$24K |
| 71045 |
Radiologic examination, chest; single view |
7,168 |
5,789 |
$23K |
| 73630 |
|
920 |
692 |
$22K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
69 |
58 |
$22K |
| 84439 |
|
1,479 |
1,341 |
$21K |
| 72100 |
|
409 |
366 |
$21K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
2,096 |
1,855 |
$18K |
| 97035 |
|
384 |
129 |
$18K |
| 71250 |
|
230 |
204 |
$17K |
| 73562 |
|
418 |
349 |
$17K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
3,449 |
2,506 |
$17K |
| 95886 |
|
166 |
108 |
$16K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
370 |
335 |
$16K |
| 82607 |
|
1,230 |
1,129 |
$15K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
309 |
272 |
$15K |
| 73610 |
|
487 |
413 |
$15K |
| 73030 |
|
605 |
508 |
$14K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
114 |
106 |
$14K |
| 83615 |
|
1,051 |
768 |
$13K |
| 97014 |
|
451 |
179 |
$12K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
7,208 |
5,694 |
$11K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
423 |
375 |
$11K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
962 |
891 |
$11K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
85 |
85 |
$11K |
| 73130 |
|
431 |
341 |
$10K |
| 82746 |
|
997 |
902 |
$10K |
| 85027 |
|
1,371 |
1,144 |
$10K |
| 73564 |
|
498 |
375 |
$10K |
| 82728 |
|
632 |
545 |
$9K |
| 84484 |
|
5,499 |
3,832 |
$8K |
| 81001 |
|
9,156 |
7,949 |
$8K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
1,070 |
369 |
$7K |
| 74018 |
|
160 |
139 |
$7K |
| 99222 |
Initial hospital care, per day, moderate complexity |
285 |
239 |
$7K |
| 99239 |
Hospital discharge day management, more than 30 minutes |
461 |
375 |
$7K |
| 73110 |
|
224 |
179 |
$6K |
| 73502 |
|
212 |
189 |
$6K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
168 |
154 |
$6K |
| 83540 |
|
590 |
530 |
$6K |
| 84153 |
|
346 |
319 |
$5K |
| 83735 |
|
937 |
773 |
$5K |
| 86140 |
|
637 |
535 |
$5K |
| 83550 |
|
549 |
495 |
$5K |
| 87581 |
|
841 |
780 |
$5K |
| 87486 |
|
841 |
780 |
$5K |
| 85610 |
|
4,674 |
3,965 |
$4K |
| 72131 |
|
45 |
37 |
$4K |
| 87186 |
|
586 |
530 |
$4K |
| 86803 |
|
154 |
149 |
$4K |
| 83690 |
|
8,241 |
7,006 |
$4K |
| 83880 |
|
1,277 |
1,016 |
$4K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
12 |
12 |
$4K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
359 |
300 |
$4K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
69 |
64 |
$4K |
| 85652 |
|
621 |
506 |
$4K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
104 |
95 |
$4K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
309 |
272 |
$3K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
16 |
12 |
$3K |
| 82378 |
|
249 |
229 |
$3K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
168 |
154 |
$3K |
| 82043 |
|
413 |
388 |
$3K |
| 96376 |
|
1,765 |
857 |
$3K |
| 82570 |
|
321 |
308 |
$3K |
| 85730 |
|
4,360 |
3,707 |
$3K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
12 |
12 |
$3K |
| 93971 |
|
28 |
26 |
$3K |
| 99215 |
Prolong outpt/office vis |
34 |
31 |
$2K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
501 |
432 |
$2K |
| J3490 |
Unclassified drugs |
1,442 |
915 |
$2K |
| 86038 |
|
113 |
106 |
$2K |
| 93270 |
|
41 |
36 |
$2K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,953 |
1,669 |
$2K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
54 |
13 |
$2K |
| 85379 |
|
1,188 |
1,022 |
$2K |
| 82803 |
|
1,966 |
1,503 |
$2K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
71 |
65 |
$2K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
92 |
84 |
$2K |
| 76642 |
|
14 |
14 |
$2K |
| 83605 |
|
1,632 |
1,304 |
$2K |
| 84550 |
|
229 |
204 |
$2K |
| 87902 |
|
15 |
12 |
$1K |
| 96367 |
|
382 |
287 |
$1K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
789 |
683 |
$1K |
| 84145 |
|
1,439 |
1,207 |
$1K |
| 93017 |
|
18 |
15 |
$1K |
| 82550 |
|
1,178 |
927 |
$1K |
| 87040 |
|
1,171 |
853 |
$1K |
| 84703 |
|
787 |
658 |
$1K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
5,697 |
4,563 |
$996.58 |
| 80076 |
|
111 |
96 |
$974.21 |
| 86850 |
|
34 |
26 |
$934.05 |
| 73590 |
|
31 |
25 |
$931.02 |
| 99217 |
|
76 |
62 |
$889.20 |
| 72040 |
|
13 |
13 |
$819.36 |
| 86900 |
|
52 |
39 |
$766.74 |
| 87070 |
|
64 |
54 |
$743.62 |
| 99223 |
Prolong inpt eval add15 m |
58 |
38 |
$702.00 |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
31 |
31 |
$695.37 |
| 97116 |
|
30 |
16 |
$665.36 |
| 11720 |
|
34 |
13 |
$654.94 |
| 73080 |
|
35 |
30 |
$586.17 |
| 84481 |
|
51 |
44 |
$575.00 |
| 80074 |
|
45 |
39 |
$573.78 |
| 36600 |
|
326 |
243 |
$572.01 |
| 83970 |
|
33 |
32 |
$568.74 |
| 84100 |
|
107 |
99 |
$532.25 |
| 83026 |
|
40 |
40 |
$503.27 |
| 80069 |
|
57 |
53 |
$493.62 |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
5,205 |
4,520 |
$434.75 |
| 99219 |
|
16 |
15 |
$410.06 |
| 81025 |
|
638 |
542 |
$356.25 |
| 84403 |
|
30 |
26 |
$322.40 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
114 |
92 |
$321.70 |
| J7050 |
Infusion, normal saline solution, 250 cc |
10,755 |
6,939 |
$295.86 |
| 94644 |
|
40 |
38 |
$271.82 |
| 90715 |
|
14 |
14 |
$260.70 |
| 87522 |
Neg quan hep c or qual rna |
17 |
12 |
$224.29 |
| 84156 |
|
39 |
38 |
$214.86 |
| 0002A |
|
64 |
63 |
$195.79 |
| 0001A |
|
74 |
68 |
$174.27 |
| 86901 |
|
64 |
51 |
$152.58 |
| 82553 |
|
133 |
106 |
$151.66 |
| 82150 |
|
22 |
17 |
$130.08 |
| 82565 |
|
32 |
31 |
$123.98 |
| 82010 |
|
134 |
105 |
$120.80 |
| 0011A |
|
27 |
26 |
$117.17 |
| 80051 |
|
15 |
14 |
$114.84 |
| 51702 |
|
107 |
97 |
$88.22 |
| 82310 |
|
12 |
12 |
$84.92 |
| 82784 |
|
13 |
13 |
$67.53 |
| 84520 |
|
16 |
15 |
$53.38 |
| 87640 |
|
19 |
17 |
$46.23 |
| J2704 |
Injection, propofol, 10 mg |
747 |
614 |
$46.18 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
240 |
210 |
$43.50 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
3,198 |
2,752 |
$42.52 |
| 0012A |
|
34 |
33 |
$37.98 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
581 |
478 |
$35.77 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
984 |
803 |
$34.76 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
819 |
674 |
$33.44 |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
26 |
24 |
$29.06 |
| J1815 |
Injection, insulin, per 5 units |
27 |
15 |
$26.46 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
170 |
136 |
$21.20 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,038 |
863 |
$17.98 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
3,829 |
3,237 |
$16.51 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
137 |
112 |
$9.23 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
390 |
320 |
$9.05 |
| J2060 |
Injection, lorazepam, 2 mg |
111 |
96 |
$5.90 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
384 |
320 |
$4.69 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
468 |
382 |
$2.93 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
858 |
723 |
$1.52 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
730 |
672 |
$1.51 |
| J7510 |
Prednisolone oral, per 5 mg |
62 |
61 |
$0.72 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
413 |
363 |
$0.62 |
| 80305 |
|
252 |
234 |
$0.00 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
460 |
388 |
$0.00 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
3,834 |
1,816 |
$0.00 |
| 94664 |
|
40 |
37 |
$0.00 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
56 |
52 |
$0.00 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
17 |
15 |
$0.00 |
| Q9954 |
Oral magnetic resonance contrast agent, per 100 ml |
103 |
88 |
$0.00 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
56 |
44 |
$0.00 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
40 |
30 |
$0.00 |
| 00731 |
|
18 |
17 |
$0.00 |
| J1956 |
Injection, levofloxacin, 250 mg |
56 |
50 |
$0.00 |
| J1940 |
Injection, furosemide, up to 20 mg |
192 |
125 |
$0.00 |
| 99024 |
|
57 |
53 |
$0.00 |
| 94760 |
|
497 |
163 |
$0.00 |
| J7611 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg |
76 |
69 |
$0.00 |